What is Irene Mannering's NPI number?

Irene Mannering's National Provider Identifier (NPI) is 1023300977, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Irene Mannering's specialty?

Irene Mannering is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Irene Mannering located?

Irene Mannering's practice location on file with NPPES is 4814 Sparks Blvd, Sparks, NV 89436.

What is Irene Mannering's phone number?

The practice phone number listed in the NPPES registry for Irene Mannering is (753) 240-6997.

Does Irene Mannering accept Medicare?

Irene Mannering is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Irene Mannering's NPI active?

Yes — Irene Mannering's NPI (1023300977) is active in the NPPES registry as of the last update on 2018-09-21.

IndividualActiveAccepts Medicare

Irene Mannering, M.D.

NPI 1023300977 · Dermatology Physician · Sparks, NV

Irene Mannering, M.D. is a Dermatology Physician provider in Sparks, NV (NPI 1023300977).

Provider details

NPI number: 1023300977
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 124024 (CA)

Practice location

4814 Sparks Blvd

Sparks, NV 89436

Phone: (753) 240-6997

Fax: (775) 323-6814

Street-level locationGet directions

More NV providers

Mailing address

640 W Moana Ln

Reno, NV 89509-4903

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 17469 (NV)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense 124024 (CA)
Allopathic & Osteopathic Physicians

Additional practice locations (2)

118 Med Surge I
University of California, Irvine Department Dermatology
Irvine, CA 92697-4375
Phone: (949) 824-4405
640 W Moana Ln
Reno, NV 89509-4903
Phone: (775) 324-0699
Fax: (775) 323-6814

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(87/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
15 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
3 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
5,094 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,930	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,151	$89
Destruction of Precancer Skin Growth, 1 Growth17000	710	$52
Biopsy of Related Skin Growth, First Growth11102	380	$91
Destruction of Skin Growth, 1-14 Growths17110	238	$110
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	146	109
Clobetasol Propionate	108	52
Ketoconazole	106	51
Hydrocortisone	71	49
Doxycycline Hyclate	63	23
Metronidazole	43	30
Fluocinonide	32	22
Desoximetasone	29	13

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,145 across 109 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2011-05-11
Last updated: 2018-09-21

Frequently asked questions

What is Irene Mannering's NPI number?: Irene Mannering's National Provider Identifier (NPI) is 1023300977, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Irene Mannering's specialty?: Irene Mannering is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Irene Mannering located?: Irene Mannering's practice location on file with NPPES is 4814 Sparks Blvd, Sparks, NV 89436.
What is Irene Mannering's phone number?: The practice phone number listed in the NPPES registry for Irene Mannering is (753) 240-6997.
Does Irene Mannering accept Medicare?: Irene Mannering is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Irene Mannering's NPI active?: Yes — Irene Mannering's NPI (1023300977) is active in the NPPES registry as of the last update on 2018-09-21.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,930	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,151	$89
Destruction of Precancer Skin Growth, 1 Growth17000	710	$52
Biopsy of Related Skin Growth, First Growth11102	380	$91
Destruction of Skin Growth, 1-14 Growths17110	238	$110
Biopsy of Related Skin Growth, Each Additional Growth

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

146

109

Clobetasol Propionate

108

Ketoconazole

106

Hydrocortisone

Doxycycline Hyclate

Metronidazole

Fluocinonide

Desoximetasone

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,145 across 109 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (2)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (2)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments